At the forefront of this movement (and as far back as 2017), the UAE government released a first-of-its-kind strategy setting a clear roadmap for developing its regional capabilities and becoming the world's premier AI destination. The UAE Strategy For Artificial Intelligence has set out its priority sectors, which include: resources and energy, logistics and transport, tourism and hospitality, healthcare, and cybersecurity. However, the sheer depth of data available means that AI and machine learning can potentially leverage insights from real-world usage to create smart medical devices, such as diagnostic imaging systems and sensors that can detect conditions such as heart disease and lung cancer. For example, researchers at a UK hospital have developed an AI system that can diagnose heart scans with greater accuracy than human cardiologists, who typically misdiagnose one in five cases. AI is a perfect match for some of cybersecurity's most complex issues, and due to its ability to analyse traffic and patterns, it can detect potential threats and take preventative action more effectively than software-based solutions.

Artificial intelligence (AI) has already proven useful in the healthcare industry, and now, two newly developed AI diagnostics systems could change how doctors diagnose heart disease and lung cancer. Cardiologists are very good at their jobs, but they're not infallible. To determine whether or not something's wrong with a patient's heart, a cardiologist will assess the timing of their heartbeat in scans. According to a report by BBC News, 80 percent of the time, their diagnosis of various heart problems is correct, but it's the remaining 20 percent that shows the process has room for improvement. To that end, a team of researchers from the John Radcliffe Hospital in Oxford, England, developed Ultromics, an AI diagnostics system that is more accurate than doctors at diagnosing heart disease. Ultromics was trained using the heart scans of 1,000 patients treated by the company's chief medical officer, Paul Leeson, as well as information about whether or not those patients went on to suffer heart problems.